NCT05890612
- Conditions
- COVID-19, Coronaviridae Infections, Coronavirus Infections, +9 more
- Locations
-
- Pfizer Korea Seoul, South Korea
Clinical trial condition
Explore clinical trials studying Respiratory Tract Infections. Study availability and eligibility vary by location and protocol.
NCT05890612
NCT06506474
NCT05866952
NCT05261139
NCT05332067
NCT05455034
NCT06804096
NCT05890599
NCT06859281
NCT06857890